Provider of genetic analysis and precision medicine services. The tests reports enable the clinicians to offer treatment plans as per the individual's genetic profile. The company is developing a genetic analysis platform for gene-related data. Clinical needs provide clinicians with an accurate basis for diagnosis and treatment, thereby enhancing their clinical benefit. The company was founded in 2015 and headquartered in Beijing, China. It has raised $25.6M in series b funding, with backing from Shenzhen Guozhong Venture Capital Management, Langmafeng Venture Capital, Shengwan Investment-SOVA CAPITAL, Shuimu Venture Capital, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Clinical Genomics space.
← All startups
Safford Decoding
Series BProvider of genetic analysis and precision medicine services. The tests reports enable the clinicians to offer treatment plans as per the individual's genetic profile. The company is developing a genetic analysis platform for gene-related data. Clinical needs provide clinicians with an accurate basis for diagnosis and treatment, thereby enhancing their clinical benefit. The company was founded in 2015 and…
About
Business model
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Precision Medicine
Institutional investors
Shenzhen Guozhong Venture Capital ManagementLangmafeng Venture CapitalShengwan Investment-SOVA CAPITALShuimu Venture CapitalTusStarCS CapitalJiangmen Ventures
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.